MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.15
+0.00 (+3.40%)
Financial Highlights (FY 2026)
Revenue
182.66M
Net Income
-56,758,535
Gross Margin
64.5%
Profit Margin
-31.1%
Rev Growth
+42.8%
D/E Ratio
4.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 182.66M 127.92M 27.35M 20.96M
Gross Profit 117.91M 82.57M 9.30M 7.12M
Operating Income -24,659,252 -15,542,633 6.75M 5.11M
Net Income -56,758,535 -35,774,691 6.20M 4.50M
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Rev Growth +42.8% +42.8% -0.5% +20.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.34M 5.34M 71.52M 80.61M
Total Equity 1.34M 1.34M 72.48M 68.20M
D/E Ratio 4.00 4.00 0.99 1.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -10,482,012 -6,973,815 9.44M 6.87M
Free Cash Flow — — 4.10M 4.11M